Literature DB >> 2915783

Correlation of magnetic resonance imaging with neuropsychological testing in multiple sclerosis.

S M Rao1, G J Leo, V M Haughton, P St Aubin-Faubert, L Bernardin.   

Abstract

Previous research has suggested that cerebral lesions observed on magnetic resonance imaging (MRI) of MS patients are clinically "silent." We examined the validity of this assertion by correlating neuropsychological test performance with MRI findings in 53 MS patients. We used a semiautomated quantitation system to measure three MRI variables: total lesion area (TLA), ventricular-brain ratio (VBR), and size of the corpus callosum (SCC). Stepwise multiple regression analyses indicated that TLA was a robust predictor of cognitive dysfunction, particularly for measures of recent memory, abstract/conceptual reasoning, language, and visuospatial problem solving. SCC predicted test performance on measures on mental processing speed and rapid problem solving, while VBR did not independently predict cognitive test findings. These findings suggest that cerebral lesions in MS produce cognitive dysfunction and that MRI may be a useful predictor of cognitive dysfunction.

Entities:  

Mesh:

Year:  1989        PMID: 2915783     DOI: 10.1212/wnl.39.2.161

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  78 in total

1.  Neuroradiological imaging and neuropsychological testing in multiple sclerosis.

Authors:  I G Ainyette; P Bowers; H Llingüin
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

2.  Multiple sclerosis and the mind.

Authors:  M A Ron; A Feinstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-01       Impact factor: 10.154

3.  Korsakoff's syndrome as the initial presentation of multiple sclerosis.

Authors:  A Vighetto; N Charles; M Salzmann; C Confavreux; G Aimard
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

4.  Towards patient collaboration in cognitive assessment: Specificity, sensitivity, and incremental validity of self-report.

Authors:  C E Schwartz; E Kozora; Q Zeng
Journal:  Ann Behav Med       Date:  1996-09

5.  Neuropsychological assessment in multiple sclerosis: a follow-up study with magnetic resonance imaging.

Authors:  C Mariani; E Farina; S F Cappa; G P Anzola; L Faglia; L Bevilacqua; R Capra; F Mattioli; L A Vignolo
Journal:  J Neurol       Date:  1991-10       Impact factor: 4.849

6.  Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome.

Authors:  Tomas Uher; Jana Blahova-Dusankova; Dana Horakova; Niels Bergsland; Michaela Tyblova; Ralph H B Benedict; Tomas Kalincik; Deepa P Ramasamy; Zdenek Seidl; Jesper Hagermeier; Manuela Vaneckova; Jan Krasensky; Eva Havrdova; Robert Zivadinov
Journal:  J Neurol       Date:  2014-06-22       Impact factor: 4.849

Review 7.  Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.

Authors:  J H Simon
Journal:  West J Med       Date:  1996-06

Review 8.  Grey matter lesions in MS: from histology to clinical implications.

Authors:  Massimiliano Calabrese; Alice Favaretto; Valeria Martini; Paolo Gallo
Journal:  Prion       Date:  2012-10-23       Impact factor: 3.931

9.  Perfusion magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis.

Authors:  Matilde Inglese; Sumita Adhya; Glyn Johnson; James S Babb; Laura Miles; Hina Jaggi; Joseph Herbert; Robert I Grossman
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-02       Impact factor: 6.200

10.  Relevance of the skewness index in DTI exploration of multiple sclerosis.

Authors:  Eliane Graulières; Jean-Albert Lotterie; Emmanuelle Cassol; Angélique Gerdelat; Michel Clanet; Isabelle Berry
Journal:  MAGMA       Date:  2008-11-08       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.